Baird Financial Group
XPH icon

Baird Financial Group’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Baird Financial Group’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.57M Sell
29,049
-289
-1% -$16.1K ﹤0.01% 1133
2025
Q4 		$1.64M Buy
29,338
+24,057
+456% +$1.25M ﹤0.01% 1102
2025
Q3 		$253K Hold
5,281
– – ﹤0.01% 1675
2025
Q2 		$214K Hold
5,281
– – ﹤0.01% 1689
2025
Q1 		$231K Hold
5,281
– – ﹤0.01% 1652
2024
Q4 		$227K Hold
5,281
– – ﹤0.01% 1644
2024
Q3 		$234K Hold
5,281
– – ﹤0.01% 1623
2024
Q2 		$210K Sell
5,281
-300
-5% -$12.2K ﹤0.01% 1668
2024
Q1 		$241K Hold
5,581
– – ﹤0.01% 1623
2023
Q4 		$232K Sell
5,581
-213
-4% -$8.07K ﹤0.01% 1594
2023
Q3 		$230K Hold
5,794
– – ﹤0.01% 1583
2023
Q2 		$237K Sell
5,794
-16,863
-74% -$696K ﹤0.01% 1569
2023
Q1 		$929K Buy
22,657
+16,651
+277% +$700K ﹤0.01% 1107
2022
Q4 		$246K Hold
6,006
– – ﹤0.01% 1529
2022
Q3 		$241K Hold
6,006
– – ﹤0.01% 1542
2022
Q2 		$252K Hold
6,006
– – ﹤0.01% 1616
2022
Q1 		$272K Hold
6,006
– – ﹤0.01% 1658
2021
Q4 		$277K Hold
6,006
– – ﹤0.01% 1708
2021
Q3 		$285K Hold
6,006
– – ﹤0.01% 1690
2021
Q2 		$311K Hold
6,006
– – ﹤0.01% 1566
2021
Q1 		$302K Sell
6,006
-65
-1% -$3.46K ﹤0.01% 1519
2020
Q4 		$316K Hold
6,071
– – ﹤0.01% 1365
2020
Q3 		$264K Sell
6,071
-950
-14% -$41.6K ﹤0.01% 1334
2020
Q2 		$302K Hold
7,021
– – ﹤0.01% 1301
2020
Q1 		$253K Buy
7,021
+65
+0.9% +$2.77K ﹤0.01% 1254
2019
Q4 		$318K Hold
6,956
– – ﹤0.01% 1307
2019
Q3 		$248K Sell
6,956
-16,142
-70% -$600K ﹤0.01% 1374
2019
Q2 		$920K Sell
23,098
-15
-0.1% -$590 ﹤0.01% 1017
2019
Q1 		$961K Sell
23,113
-81,377
-78% -$3.31M 0.01% 863
2018
Q4 		$3.83M Sell
104,490
-51,943
-33% -$2.22M 0.03% 472
2018
Q3 		$7.34M Buy
156,433
+26,124
+20% +$1.24M 0.05% 368
2018
Q2 		$5.61M Buy
130,309
+287
+0.2% +$12.1K 0.04% 406
2018
Q1 		$5.44M Buy
130,022
+1,491
+1% +$65K 0.04% 407
2017
Q4 		$5.59M Sell
128,531
-337
-0.3% -$14.3K 0.04% 399
2017
Q3 		$5.48M Sell
128,868
-3,399
-3% -$144K 0.04% 399
2017
Q2 		$5.69M Buy
132,267
+809
+0.6% +$34.1K 0.04% 380
2017
Q1 		$5.5M Buy
131,458
+23,753
+22% +$968K 0.04% 372
2016
Q4 		$4.21M Buy
107,705
+4,057
+4% +$165K 0.04% 404
2016
Q3 		$4.58M Sell
103,648
-20,030
-16% -$910K 0.04% 386
2016
Q2 		$5.17M Buy
123,678
+1,663
+1% +$70.4K 0.05% 352
2016
Q1 		$4.91M Buy
122,015
+1,049
+0.9% +$44.4K 0.05% 354
2015
Q4 		$6.19M Buy
120,966
+46
+0% +$2.34K 0.06% 301
2015
Q3 		$5.67M Sell
120,920
-732
-0.6% -$44.1K 0.06% 297
2015
Q2 		$7.58M Buy
+121,652
New +$7.58M 0.07% 256

Other funds holding XPH

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
Envestnet Portfolio Solutions
Envestnet Portfolio Solutions Chicago, Illinois $18.1B AUM 15% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Baird Financial Group's XPH Position: Q1 2026 in Review

Baird Financial Group reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 0.99% in Q1 2026, selling an estimated $16.1K and leaving 29,049 shares worth $1.57M. The position accounts for ﹤0.01% of the portfolio, ranked #1133.

Baird Financial Group first reported a position in XPH in Q2 2015 and has held it in 44 quarters since. The position peaked at $7.58M in Q2 2015. 82 funds tracked by Wall St. Rank hold XPH as of Q1 2026.

  • Baird Financial Group held 29,049 shares of State Street SPDR S&P Pharmaceuticals ETF worth $1.57M as of Q1 2026.
  • Baird Financial Group sold 289 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2026, an estimated $16.1K.
  • State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1133 holding.
  • Baird Financial Group first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q2 2015 and has held it in 44 quarters since.
  • Baird Financial Group's State Street SPDR S&P Pharmaceuticals ETF position peaked at $7.58M in Q2 2015.
  • 82 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.